Coronavirus: Clinical Trials

Department of Health and Social Care written question – answered on 3rd July 2020.

Alert me about debates like this

Photo of Diana R. Johnson Diana R. Johnson Labour, Kingston upon Hull North

To ask the Secretary of State for Health and Social Care, what discussions officials in his Department have had with (a) sponsors of the University of Oxford's Recovery trial and (b) suppliers of each medication being used in that trial to ensure that adequate supplies of those medications are in place to treat covid-19 patients in the event that the trial has positive results.

Photo of Jo Churchill Jo Churchill The Parliamentary Under-Secretary for Health and Social Care

Officials in the Department have regular conversations with the RECOVERY trial leads about the trial and central supply of medicines to the trial.

Teams in the Department, Public Health England, the Medicines and Healthcare products Regulatory Agency and NHS England and NHS Improvement also have daily discussions with suppliers and manufacturers of medicines, including about supplies to support clinical trials. In addition, the Department has been securing additional supplies of a number of medicines, which would ensure sufficient stocks are available to be rapidly deployed for National Health Service patients, should clinical trial evidence show it to be safe and effective to do so. The Department continues to review supply requirements as further clinical evidence becomes available.

Does this answer the above question?

Yes1 person thinks so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.